Emergency Medicine Cardiac Research and Education Group


CRUSADE
CRUSADE Quality Improvement Initiative

Launched in 2001, CRUSADE is a national quality improvement initiative, designed to increase the practice of evidence-based medicine for patients diagnosed with non-ST segment elevation acute coronary syndromes (NSTE ACS) (i.e., unstable angina or NSTE myocardial infarction).

Through a continuous cycle of data collection, performance feedback and quality improvement interventions, over 500 participating sites in the US are consistently improving the standard of care for patients with NSTE ACS. Because of the dedication of the participating hospitals to this mission, over 200,000 cases have been submitted to the CRUSADE database. For more information visit the CRUSADE website.

In 2007, a milestone occurred. Duke Clinical Research Institute and its CRUSADE leadership joined forces with the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR™) to launch a new initiative to improve the safety and outcomes for patients with ACS through the development of NCDR-ACTION™. This initiative will combine the data collection and quality reporting features of two leading national ACS registries to create the largest and most comprehensive national cardiovascular patient database ever developed. For more information visit the NCDR-ACTION Registry™ visit the website or call 800-257-4737 for more information.




Implementation of a Statewide System for Coronary Reperfusion for ST-Segment Elevation Myocardial Infarction



JAMA 2007; Advance online publication View citation

Context: Despite 2 decades of evidence demonstrating benefits from prompt coronary reperfusion, registries continue to show that many patients with ST-segment elevation myocardial infarction (STEMI) are treated too slowly or not at all.

Objective: To establish a statewide system for reperfusion, as exists for trauma care, to overcome systematic barriers.

Design and Setting: A quality improvement study that examined the change in speed and rate of coronary reperfusion after system implementation in 5 regions in North Carolina involving 65 hospitals and associated emergency medical systems (10 percutaneous coronary intervention [PCI] hospitals and 55 non-PCI hospitals).

Patients: A total of 1164 patients with STEMI (579 preintervention and 585 postintervention) eligible for reperfusion were treated at PCI hospitals (median age 61 years, 31% women, 4% Killip class III or IV). A total of 925 patients with STEMI (518 preintervention and 407 postintervention) were treated at non-PCI hospitals (median age 62 years, 32% women, 4% Killip class III or IV).

Interventions: Early diagnosis and the most expedient coronary reperfusion method at each point of care: emergency medical systems, emergency department, catheterization laboratory, and transfer. Within 5 regions, PCI hospitals agreed to provide single call catheterization laboratory activation by emergency medical personnel, accept patients regardless of bed availability, and improve STEMI care for the entire region regardless of hospital affiliation.

Main Outcome Measures: Reperfusion times and rates 3 months before (July to September 2005) and 3 months after (January to March 2007) a year-long implementation.

Results: Median reperfusion times significantly improved according to first door-todevice (presenting to PCI hospital 85 to 74 minutes, P.001; transferred to PCI hospital 165 to 128 minutes, P.001), door-to-needle in non-PCI hospitals (35 to 29 minutes, P=.002), and door-in to door-out for patients transferred from non-PCI hospitals (120 to 71 minutes, P.001). Nonreperfusion rates were unchanged (15%) in non-PCI hospitals and decreased from 23% to 11% in the PCI hospitals. For patients presenting to or transferred to PCI hospitals, clinical outcomes including death, cardiac arrest, and cardiogenic shock did not significantly change following the intervention.

Conclusions: A statewide program focused on regional systems for reperfusion for STEMI can significantly improve quality of care. Further research is needed to ensure that programs that result in improved application of reperfusion treatments will lead to reductions in mortality and morbidity from STEMI.




General navigation: Home | Member roster | Consultation | Our history | Contact
News & Events: Literature news archives | EM and related events
Education: Symposium monographs | CME monographs | Articles & Print | Multimedia
Publications: Member publications | Monographs

Legal information

EMCREG™ - International
Department of Emergency Medicine
University of Cincinnati College of Medicine
ML 0769, Room 6107
231 Albert Sabin Way
Cincinnati, Ohio 45267-0769

Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)



Advanced Search

28 January 2010
Study results show that the TIMI risk score predicts outcomes in in emergency department with suspected ACS.
28 January 2010
Serial measurement of NT-proBNP predicts new-onset heart failure and cardiovascular mortality in elderly.
15 January 2010
Individual risk profiling of ACS patients could optimize therapeutic treatment choices.
15 January 2010
Results of the PLATO trial show that the reversible P2Y12 inhibitor ticagrelor reduces death and cardiovascular events compared with clopidogrel therapy in ACS patients.
5 January 2010
Study shows that high sensitive cardiac troponin I level is a useful prognostic marker of mortality in chronic heart failure patients.
23 December 2009
The largest and most comprehensive meta-analysis ever concludes that CRP is unlikely to be a causal factor for cardiovascular disease.
16 December 2009
Research shows that a substantial number of STEMI patients still receive fibrinolytic therapy at PCI capable centers.
11 December 2009
Denmark researchers report in Lancet that relative risk for hospitalization for bleeding increased with all drug combinations and with each additional drug used.
3 December 2009
Researchers report that prehospital triage significantly reduces treatment delay and improves outcomes in STEMI patients who undergo PCI.
30 November 2009
Researchers report that the to reperfusion, beginning with symptom onset time, determines the extent of reversible myocardial injury in STEMI patients undergoing PCI.
19 November 2009
Data presented at the AHA 2009 Scientific Sessions shows that dabigatran when added to dual anti-platelet therapy results in a “low and acceptable bleeding rate” in AMI patients.
19 November 2009
A must-read update for the management of acute coronary syndrome.
19 November 2009
Data presented at the AHA 2009 Scientific Sessions indicates that CT angiography in the emergency room can successfully triage at-risk chest-pain patients faster and cheaper than standard of care testing.
19 November 2009
Recent meta-analysis reveals that high-risk STEMI patients given adjunctive glycoprotein (GP) IIb/IIIa inhibitor therapy and undergo primary angioplasty have a reduced risk for death.
NEWS ARCHIVES:
©Copyright EMCREG-International™. All rights reserved